Journal of Immune Based Therapies and Vaccines Improved Generation of Anti-tumor Immunity by Antigen Dose Limitation

Background: The malignant cells of cutaneous T cell lymphoma (CTCL) display immunogenic peptides derived from the clonal T cell receptor (TCR) providing an attractive model for refinement of anti-tumor immunization methodology. To produce a clinically meaningful anti-tumor response, induction of cytotoxic anti-CTCL cells must be maximized while suppressive T regulatory cells (Treg) should be minimized. We have demonstrated that engulfment of apoptotic CTCL cells by dendritic cells (DC) can lead to either CD8 anti-CTCL responses or immunosuppressive Treg induction. Treg generation is favored when the number of apoptotic cells available for ingestion is high.

[1]  W. Zou.  Regulatory T cells, tumour immunity and immunotherapy , 2006, Nature Reviews Immunology.

[2]  William L Redmond,et al.  Peripheral tolerance of CD8 T lymphocytes. , 2005, Immunity.

[3]  Jennifer Trinh,et al.  Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. , 2005, Blood.

[4]  L. Kanz,et al.  Dendritic cells in vaccination therapies of human malignant disease. , 2004, Blood reviews.

[5]  P. Brossart,et al.  Cellular Immunotherapy with Dendritic Cells in Cancer: Current Status , 2004, Stem cells.

[6]  I. Mellman,et al.  Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation , 2003, The Journal of experimental medicine.

[7]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[8]  M. Girardi,et al.  Transimmunization and the evolution of extracorporeal photochemotherapy. , 2002, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[9]  M. Girardi,et al.  Transimmunization, a novel approach for tumor immunotherapy. , 2002, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[10]  T. Schumacher,et al.  Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[11]  R. Steinman,et al.  Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. , 2001, Cancer research.

[12]  R. Knobler,et al.  Extracorporeal Photochemoimmunotherapy in Cutaneous T Cell Lymphomas , 2001, Annals of the New York Academy of Sciences.

[13]  R. Tigelaar,et al.  Induction of human tumor‐loaded dendritic cells , 2001, International journal of cancer.

[14]  G. Schuler,et al.  Viral vectors for dendritic cell-based immunotherapy. , 2001, Current topics in microbiology and immunology.

[15]  R M Zinkernagel,et al.  Localization dose and time of antigens determine immune reactivity. , 2000, Seminars in immunology.

[16]  R. Steinman,et al.  The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells , 2000, The Journal of experimental medicine.

[17]  M. Toda,et al.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.

[18]  E. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[19]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[20]  R. Edelson.  Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. , 1980, Journal of the American Academy of Dermatology.

[21]  D. Warburton,et al.  Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. , 1979, The Journal of investigative dermatology.

[22]  M. G. Lewis,et al.  Target Role of Langerhans Cells in Mycosis Fungoides: Transmission and Immuno‐Electron Microscopic Studies , 1979, Journal of cutaneous pathology.

[23]  T. Waldmann,et al.  The Sézary syndrome: a malignant proliferation of helper T cells. , 1976, The Journal of clinical investigation.

[24]  E. Ranieri.  Cytotoxic T-Cells , 2014, Methods in Molecular Biology.

[25]  H. Waldmann,et al.  Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.

[26]  Leonard C. Harrison,et al.  Regulatory lymphocytes: Antigen-induced regulatory T cells in autoimmunity , 2003, Nature Reviews Immunology.

[27]  J. Demengeot,et al.  CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. , 2002, European journal of immunology.

[28]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.